vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $25.8M, roughly 1.2× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -32.1%, a 71.5% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -4.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $25.0K). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -0.1%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
FNLC vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $31.1M |
| Net Profit | $10.2M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 48.1% | -9.9% |
| Net Margin | 39.4% | -32.1% |
| Revenue YoY | 17.5% | -4.5% |
| Net Profit YoY | 39.7% | -52.0% |
| EPS (diluted) | $0.91 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | — | ||
| Q3 25 | $24.5M | $31.1M | ||
| Q2 25 | $22.5M | — | ||
| Q1 25 | $21.8M | $35.2M | ||
| Q4 24 | $22.0M | $32.6M | ||
| Q3 24 | $20.5M | $24.7M | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.5M | $35.7M |
| Q4 25 | $10.2M | — | ||
| Q3 25 | $9.1M | $-10.0M | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $7.1M | $-14.8M | ||
| Q4 24 | $7.3M | $-6.6M | ||
| Q3 24 | $7.6M | $-16.2M | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $6.0M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 48.1% | — | ||
| Q3 25 | 45.2% | -9.9% | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 39.3% | -25.7% | ||
| Q4 24 | 39.5% | -6.0% | ||
| Q3 24 | 44.6% | -46.9% | ||
| Q2 24 | 38.8% | — | ||
| Q1 24 | 39.3% | -2.5% |
| Q4 25 | 39.4% | — | ||
| Q3 25 | 37.0% | -32.1% | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.5% | -42.0% | ||
| Q4 24 | 33.1% | -20.2% | ||
| Q3 24 | 36.9% | -65.7% | ||
| Q2 24 | 32.1% | — | ||
| Q1 24 | 32.5% | 43.8% |
| Q4 25 | $0.91 | — | ||
| Q3 25 | $0.81 | $-0.29 | ||
| Q2 25 | $0.72 | — | ||
| Q1 25 | $0.63 | $-0.47 | ||
| Q4 24 | $0.66 | $-0.25 | ||
| Q3 24 | $0.68 | $-0.53 | ||
| Q2 24 | $0.55 | — | ||
| Q1 24 | $0.54 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | $95.5M | $136.0M |
| Stockholders' EquityBook value | $283.1M | $-10.5M |
| Total Assets | $3.2B | $235.2M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | $136.0M | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | $124.9M | ||
| Q4 24 | $95.0M | $111.3M | ||
| Q3 24 | $95.0M | $106.3M | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | $97.1M |
| Q4 25 | $283.1M | — | ||
| Q3 25 | $274.6M | $-10.5M | ||
| Q2 25 | $265.5M | — | ||
| Q1 25 | $259.7M | $2.2M | ||
| Q4 24 | $252.5M | $15.4M | ||
| Q3 24 | $256.8M | $-3.9M | ||
| Q2 24 | $244.7M | — | ||
| Q1 24 | $242.6M | $17.7M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | $235.2M | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | $237.7M | ||
| Q4 24 | $3.2B | $255.4M | ||
| Q3 24 | $3.1B | $246.8M | ||
| Q2 24 | $3.1B | — | ||
| Q1 24 | $3.0B | $246.2M |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | 56.05× | ||
| Q4 24 | 0.38× | 7.20× | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $1.8M |
| Free Cash FlowOCF − Capex | $34.6M | $25.0K |
| FCF MarginFCF / Revenue | 133.9% | 0.1% |
| Capex IntensityCapex / Revenue | 12.5% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | — | ||
| Q3 25 | $12.9M | $1.8M | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $2.2M | $1.2M | ||
| Q4 24 | $26.0M | $-6.1M | ||
| Q3 24 | $9.8M | $-613.0K | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $-1.5M | $-1.4M |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | $25.0K | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $828.0K | $-4.3M | ||
| Q4 24 | $24.6M | $-8.6M | ||
| Q3 24 | $9.6M | $-4.0M | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-1.8M | $-7.8M |
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | 0.1% | ||
| Q2 25 | 32.1% | — | ||
| Q1 25 | 3.8% | -12.1% | ||
| Q4 24 | 111.7% | -26.3% | ||
| Q3 24 | 47.0% | -16.3% | ||
| Q2 24 | 32.9% | — | ||
| Q1 24 | -9.8% | -21.8% |
| Q4 25 | 12.5% | — | ||
| Q3 25 | 1.2% | 5.6% | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 6.2% | 15.5% | ||
| Q4 24 | 6.7% | 7.5% | ||
| Q3 24 | 0.5% | 13.9% | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.8% | 17.8% |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FNLC
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
